Capricor Therapeutics

Max Biopharma, Inc. is a biotechnology company based in Santa Monica, CA, focused on developing innovative therapeutic solutions through their unique approach to medicine. Their pipeline includes promising candidates such as Oxy133 and Oxy210, highlighting their commitment to advancing healthcare through scientific excellence. The company is supported by a team of dedicated scientific and business advisors, who contribute to its mission of harnessing oxysterol therapeutics. By emphasizing research and development, Max Biopharma aims to address significant medical needs and improve patient outcomes. Generated from the website

Genervon Biopharmaceuticals is a clinical-stage biopharmaceutical company based in Pasadena, CA, dedicated to pioneering innovative approaches to drug development for complex neurological disorders. With a focus on multi-target drug development, the company has synthesized GM6, a peptide that passes through the blood-brain barrier, aiming to improve clinical outcomes for conditions such as ALS, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. For over twenty years, Genervon has been committed to research and development in the pursuit of curative therapies for neurodegenerative diseases, utilizing a master regulatory approach to address the common underlying pathophysiology of these disorders. The company is actively seeking partners to advance GM6 from its development phase into a marketable therapy for patients in need. Generated from the website